Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?

Tombal, Bertrand

doi:10.1093/annonc/mdu553

Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?

Tombal, Bertrand

(2015) Annals of Oncology — Vol. 26, n° 2, p. 257-258 (2015)

Files

Tombal-2015-Assessingthebenefitofbone.pdf

Restricted Access
Adobe PDF
52.1 KB

Request a copy

Details

Authors

Tombal, BertrandUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCLouvain(SLuc) Service d'urologie

Citations

APA
Chicago
FWB

Tombal, B. (2015). Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point’s definition? Annals of Oncology, 26(2), 257-258. https://doi.org/10.1093/annonc/mdu553 (Original work published 2015)